CiMaas BV and PharmaCell BV enter a collaborative agreement
CiMaas BV, a company developing cellular immunotherapy for cancer, and PharmaCell BV, a leading Contract Manufacturing Organization for Cellular Therapies […]
CiMaas BV, a company developing cellular immunotherapy for cancer, and PharmaCell BV, a leading Contract Manufacturing Organization for Cellular Therapies […]
Dr Yvo Graus, PhD, MBA, will join the management team of CiMaas. Yvo Graus is an immunologist and has extensive
Drs D.A. van den Noort, MD, and member of the Board of Directors of Bioseutica, has been appointed as first
Out of 75 applicants, 20 young companies have been nominated to receive an innovation award in November 2015. CiMaas is